Shuho issue 689 interviews David Kita, Ph.D., Co-Founder and Vice President of R&D, Verseon Corporation, about modeling a more diverse chemical space for drug discovery.
MSA Partners recently released a new report, “Ushering in the Age of Biosimilars.” The report dertails the FDA’s draft guidelines for biosimilar approval, the status of biosimilars in Europe, and industry activities.
Research & Consulting
The cornerstone of any successful business is intelligence. MSA researches markets, industry trends, regulatory policies, and public sentiment to provide evidence-based information and clear guidance.
-----»
Positioning
Building off its research expertise, MSA helps its clients successfully position themselves in the market. MSA offers outreach, liaison, point, and principal services..
-----»
Communications
MSA helps clients target their messages to key external and internal audiences. Fully bilingual, MSA works with clients to optimize communication between their offices in the US and Japan.
-----»
